Guru Ownership Trend
Guru Analysis for Soleno Therapeutics, Inc. (SLNO)
Soleno Therapeutics, Inc. (SLNO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $25.56 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $6.44 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who opened a new position. Conversely, Cliff Asness reduced exposure by 64.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Soleno Therapeutics, Inc. (SLNO)
Major holders include Renaissance Technologies (RenTech) ($14.98 M), Cliff Asness ($708,169), Joel Greenblatt ($458,743). According to the latest reported data, 3 tracked investment managers collectively hold approximately 482,154 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $6.44 M, with 2 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 2 fully exited SLNO. The total reported sell value was $8.59 M.
Yes, 1 managers opened new positions in SLNO, and 1 increased their existing holdings. The total reported buy value was $15.03 M.